Associate Professor Amanda Gwee MBBS FRACP DTMH PhD is the Leader of the Antimicrobials Group at the Murdoch Children's Research Institute. She is a general paediatrician, infectious diseases physician and clinical pharmacologist as well as the Clinical Lead of Research in the Department of General Medicine at the Royal Children’s Hospital Melbourne. In addition, she is an Associate Professor in the Department of Paediatrics, at the University of Melbourne.
Her research program focuses on optimising antimicrobial use and access in children and includes national and international clinical trials, pharmacokinetic/pharmacodynamic studies, and cohort studies. Amanda is passionate about improving medication use in children and is therefore involved in several international guideline/expert groups (European Society for Paediatric Infectious Diseases, WHO, Therapeutic Guidelines). She created and leads the Australasian KIDS DOSE consortium, a network of paediatric clinician researchers across 17 hospital/research institutions in Australia and New Zealand, dedicated to improving equity in access to optimal antimicrobial use in children.
Associate Professor Amanda Gwee MBBS FRACP DTMH PhD is the Leader of the Antimicrobials Group at the Murdoch Children's Research Institute. She is a general paediatrician, infectious diseases physician and clinical pharmacologist as well as the...
Associate Professor Amanda Gwee MBBS FRACP DTMH PhD is the Leader of the Antimicrobials Group at the Murdoch Children's Research Institute. She is a general paediatrician, infectious diseases physician and clinical pharmacologist as well as the Clinical Lead of Research in the Department of General Medicine at the Royal Children’s Hospital Melbourne. In addition, she is an Associate Professor in the Department of Paediatrics, at the University of Melbourne.
Her research program focuses on optimising antimicrobial use and access in children and includes national and international clinical trials, pharmacokinetic/pharmacodynamic studies, and cohort studies. Amanda is passionate about improving medication use in children and is therefore involved in several international guideline/expert groups (European Society for Paediatric Infectious Diseases, WHO, Therapeutic Guidelines). She created and leads the Australasian KIDS DOSE consortium, a network of paediatric clinician researchers across 17 hospital/research institutions in Australia and New Zealand, dedicated to improving equity in access to optimal antimicrobial use in children.
Top Publications
Sosnin, N, Curtis, N, Cranswick, N, Chiletti, R, Gwee, A.
Vancomycin is commonly under‐dosed in critically ill children and neonates.
British Journal of Clinical Pharmacology
85(11)
:
2591 -2598
2019
view publication
Catalano, AC, Cranswick, NE, Grindlay, J, Creati, M, Danchin, MH, Robinson, J, Williams, N, Gwee, A.
Unintended consequences of a cautious approach to e‐cigarette laws.
The Medical Journal of Australia
211(4)
:
190 -190.e1
2019
view publication
Gwee, A, Cranswick, N, McMullan, B, Bolisetty, S, Hunt, RW, Curtis, N, Duffull, SB.
Defining Target Vancomycin Trough Concentrations for Treating Staphylococcus aureus Infection in Infants Aged 0 to 90 Days.
JAMA Pediatrics
173(8)
:
791 -793
2019
view publication
Andrew, EC, Connell, T, Robinson, P, Curtis, N, Massie, J, Robertson, C, Harrison, J, Shanthikumar, S, Bryant, PA, Starr, M, et al.
Pulmonary Mycobacterium abscessus complex in children with cystic fibrosis: A practical management guideline.
Journal of Paediatrics and Child Health
55(5)
:
502 -511
2019
view publication
Gwee, A, Cranswick, N, McMullan, B, Perkins, E, Bolisetty, S, Gardiner, K, Daley, A, Ward, M, Chiletti, R, Donath, S, et al.
Continuous Versus Intermittent Vancomycin Infusions in Infants: A Randomized Controlled Trial.
Pediatrics
143(2)
:
e20182179
2019
view publication